LOADING
Comparing Microsoft Corporation (MSFT) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | TMO |
|---|---|---|
| Price | $390.99 | $528.51 |
| Change Today | +1.53% | +0.28% |
| Market Cap | $2.86T | $195.9B |
| P/E Ratio | 22.9 | 29.0 |
| Forward P/E | 19.8 | 21.2 |
| PEG Ratio | 1.19 | 1.74 |
| EPS | $16.79 | $18.18 |
| Revenue Growth (YoY) | 18.3% | 6.2% |
| Profit Margin | 39.3% | 15.1% |
| Return on Equity | 34.0% | 13.5% |
| Dividend Yield | 0.93% | 0.34% |
| Beta | 1.13 | 0.87 |
| 52-Week High | $551.05 | $642.71 |
| 52-Week Low | $349.20 | $401.89 |
| Volume | 28.9M | 1.2M |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Microsoft Corporation offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.